Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Dr. Reddy's Laboratories, Inc.

Dr. Reddy's Laboratories, Inc. Recalls

All product recalls associated with Dr. Reddy's Laboratories, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

167

Past Year

Class I (Serious)

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 121–140 of 167 recalls

Zenatane 30mg Capsules (Dr. Reddy's) – Dissolution Failure (2017)

Failed Dissolution Specifications: out of specification results observed for low dissolution.

Class IIModerate

FDAMay 22, 2017Nationwide• Dr. Reddy's Laboratories, Inc.

Rivastigmine Capsules (Dr. Reddy's) - Cross-Contamination Risk (2017)

Cross-contamination with other products -Related Substances test for Rivastigmine Tartrate Capsules USP, 1.5 mg showed a peak for Ranitidine.

Class IIILow

FDAMar 6, 2017Nationwide• Dr. Reddy's Laboratories, Inc.

Zenatane Isotretinoin 30mg (Dr. Reddy's) – Dissolution Failure (2017)

Failed dissolution specifications - low dissolution results at S3 stage.

1...5 678 9

Page 7 of 9Next

Class III

Low

FDAFeb 15, 2017Nationwide• Dr. Reddy's Laboratories, Inc.

Zenatane Capsules 20mg (Dr. Reddy's) – Dissolution Specification Failure (2017)

Failed dissolution specifications - low dissolution results at S3 stage.

Class IIILow

FDAFeb 15, 2017Nationwide• Dr. Reddy's Laboratories, Inc.

Zenatane Isotretinoin 40mg (Dr. Reddy's) – Dissolution Failure (2017)

Failed dissolution specifications - low dissolution results at S3 stage.

Class IIILow

FDAFeb 15, 2017Nationwide• Dr. Reddy's Laboratories, Inc.

Zenatane Capsules 10mg (Dr. Reddy's) – Dissolution Specification Failure (2017)

Failed dissolution specifications - low dissolution results at S3 stage.

Class IIILow

FDAFeb 15, 2017Nationwide• Dr. Reddy's Laboratories, Inc.

Docetaxel Injection (Dr. Reddy's) – Defective Container (2017)

Defective Container: Product complaints received of defect in the seal of the Docetaxel injection vials that the aluminum seal and/or stopper is removed when the cap is flipped off.

Class IIModerate

FDAJan 9, 2017Nationwide• Dr. Reddy's Laboratories, Inc.

Flucanozole Tablets 100mg (Dr. Reddy's) – Failed Dissolution (2016)

Failed Dissolution Specifications; 18 month stability time point

Class IIModerate

FDADec 28, 2016Nationwide• Dr. Reddy's Laboratories, Inc.

Flucanozole Tablets 50mg (Dr. Reddy's) – Failed Dissolution (2016)

Failed Dissolution Specifications; 18 month stability time point

Class IIModerate

FDADec 28, 2016Nationwide• Dr. Reddy's Laboratories, Inc.

Flucanozole Tablets 150mg (Dr. Reddy's) – Failed Dissolution (2016)

Failed Dissolution Specifications; 18 month stability time point

Class IIModerate

FDADec 28, 2016Nationwide• Dr. Reddy's Laboratories, Inc.

Flucanozole Tablets 200mg (Dr. Reddy's) – Failed Dissolution (2016)

Failed Dissolution Specifications; 18 month stability time point

Class IIModerate

FDADec 28, 2016Nationwide• Dr. Reddy's Laboratories, Inc.

Olanzapine Tablets (Dr. Reddy's) – Impurity Specification (2016)

Failed impurities/degradation specifications: due to out-of-specification result for the Related Substance Compound C (Impurity 6 - N-Oxide at the 18 month stability station.

Class IIILow

FDAOct 13, 2016Nationwide• Dr. Reddy's Laboratories, Inc.

Zenatane (Dr. Reddy's) – Failed Dissolution Specs (2016)

Failed Dissolution Specifications

Class IIILow

FDAAug 29, 2016Nationwide• Dr. Reddy's Laboratories, Inc.

Sirolimus Tablets (Dr. Reddy's) – impurity secorapamycin (2016)

Failed impurities/degradation: out of specification result for impurity secorapamycin.

Class IIILow

FDAJun 3, 2016Nationwide• Dr. Reddy's Laboratories, Inc.

CVS Acid Controller (Dr. Reddy's) – Impurity Specification Failure (2016)

Failed impurities/degradation specification: An out of specification results has been determined for an individual related substance during stability testing at the 18th month interval for the Famotidine 10 mg Tablet, USP.

Class IIILow

FDAApr 22, 2016Nationwide• Dr. Reddy's Laboratories, Inc.